Related Articles
Ovarian hyperstimulation in premenopausal women during adjuvant tamoxifen treatment for endocrine‑dependent breast cancer: A report of two cases
Antitumor activity of chemoendocrine therapy in premenopausal and postmenopausal models with human breast cancer xenografts
Efficacy of goserelin plus anastrozole in premenopausal women with advanced or recurrent breast cancer refractory to an LH-RH analogue with tamoxifen: Results of the JMTO BC08-01 phase II trial
ADJUVANT CHEMOENDOCRINE THERAPY FOR EARLY BREAST-CANCER - IS IT WORTHWHILE - (REVIEW)
Breast cancer in the contralateral breast: incidence and histopathology after unilateral radical treatment of the first breast cancer.